About Jointechlabs, Inc.
Jointechlabs is an emerging leader in point-of-care regenerative medicine therapies worldwide, pioneering innovative solutions for minimally invasive, autologous treatments.
Our flagship technology, MiniTC®, is FDA-cleared for microfat processing, enabling clinicians to harness the regenerative potential of a patient’s own adipose tissue in a simple, efficient, and standardized manner.
Additionally, our Mini-Stem System® is CE-Mark approved for stromal vascular fraction (SVF) processing outside the USA, offering advanced regenerative solutions for international markets.
Mini-Stem System is the world’s first product to produce injectable microfat (MFAT) and isolate Stromal Vascular Fraction (SVF) from fat, bringing joint pain and arthritis relief to the EU.
At Jointechlabs, we are committed to transforming the future of regenerative medicine by making these cutting-edge therapies more accessible, efficient, and clinically impactful.
👉Follow us on: Website | Facebook | Instagram | X | YouTube | Newsletter